$1.36
9.68% day before yesterday
Nasdaq, May 16, 10:16 pm CET
ISIN
CA68620P1018
Symbol
OGI
Sector
Industry

OrganiGram Holdings Inc Stock price

$1.36
+0.32 30.77% 1M
-0.12 8.11% 6M
-0.25 15.53% YTD
-0.67 33.00% 1Y
-3.76 73.44% 3Y
-5.12 79.01% 5Y
-0.26 16.18% 10Y
Nasdaq, Closing price Fri, May 16 2025
+0.12 9.68%
ISIN
CA68620P1018
Symbol
OGI
Sector
Industry

Key metrics

Market capitalization $171.71m
Enterprise Value $120.41m
P/E (TTM) P/E ratio 20.00
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.87
P/S ratio (TTM) P/S ratio 1.23
P/B ratio (TTM) P/B ratio 0.67
Revenue growth (TTM) Revenue growth 22.89%
Revenue (TTM) Revenue $139.05m
EBIT (operating result TTM) EBIT $-55.59m
Free Cash Flow (TTM) Free Cash Flow $-15.88m
Cash position $57.93m
EPS (TTM) EPS $0.06
P/E forward 15.28
P/S forward 0.97
EV/Sales forward 0.68
Short interest 5.92%
Show more

Is OrganiGram Holdings Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,790 stocks worldwide.

OrganiGram Holdings Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a OrganiGram Holdings Inc forecast:

4x Buy
80%
1x Hold
20%

Analyst Opinions

5 Analysts have issued a OrganiGram Holdings Inc forecast:

Buy
80%
Hold
20%

Financial data from OrganiGram Holdings Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
139 139
23% 23%
100%
- Direct Costs 139 139
2% 2%
100%
-0.09 -0.09
100% 100%
0%
- Selling and Administrative Expenses 39 39
15% 15%
28%
- Research and Development Expense 6.57 6.57
39% 39%
5%
-45 -45
43% 43%
-33%
- Depreciation and Amortization 10 10
25% 25%
7%
EBIT (Operating Income) EBIT -56 -56
40% 40%
-40%
Net Profit 11 11
105% 105%
8%

In millions USD.

Don't miss a Thing! We will send you all news about OrganiGram Holdings Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

OrganiGram Holdings Inc Stock News

Positive
Seeking Alpha
one day ago
Organigram Global reported record-high revenues for Q2 and improved net income. The company is now selling cannabis beverages in Canada and hemp-derived cannabis beverages in the US. Organigram Global is ramping up its facilities in Canada to meet international demand.
Neutral
Seeking Alpha
6 days ago
Organigram Global Inc. (NASDAQ:OGI ) Q2 2025 Earnings Conference Call May 12, 2025 8:00 AM ET Company Participants Max Schwartz - Investor Relations Beena Goldenberg - Chief Executive Officer Greg Guyatt - Chief Financial Officer Conference Call Participants Aaron Grey - Alliance Global Partners Frederico Gomes - ATB Capital Markets Yewon Kang - Canaccord Genuity Operator Good morning. My name ...
Neutral
Business Wire
6 days ago
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, announced its record results for the second quarter ended March 31, 2025 (“Q2 Fiscal 2025”). The Q2 Fiscal 2025 results include a full quarter of consolidated financials from the Company's acquisition of Motif Labs Ltd. ("Motif") on December 6...
More OrganiGram Holdings Inc News

Company Profile

OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. Its products include strains, cannabis oils, and vaporizrs. The company was founded on July 5, 2010 and is headquartered in Moncton, Canada.

Head office Canada
CEO Beena Goldenberg
Employees 898
Founded 2010
Website www.organigram.ca

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today